TheraRadar
Data updated: May 26, 2026

SODIUM TETRADECYL SULFATE

Cardiovascular Approved 2019-12-09

SODIUM TETRADECYL SULFATE is indicated for the treatment of Varicose Veins.

Source: FDA Label • Hikma
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
1
Indication
--
Phase 3 Trials
6
Years on Market

Details

Status
Prescription
First Approved
2019-12-09
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Hikma
Active Ingredient: SODIUM TETRADECYL SULFATE

SODIUM TETRADECYL SULFATE Approval History

2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2019 to 2019
Dec 2019 ORIGINAL
Update

What SODIUM TETRADECYL SULFATE Treats

1 indications

SODIUM TETRADECYL SULFATE is approved for 1 conditions since its original approval in 2019. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Varicose Veins
Source: FDA Label

SODIUM TETRADECYL SULFATE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Indication competitors

2

Same indication, different mechanism — what else might this patient receive?

VARITHENA
PROVENSIS
2013 1 indic.
ASCLERA
CHEMISCH FBRK
2010 3 indic.

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to SODIUM TETRADECYL SULFATE

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ASCLERA
POLIDOCANOL
1 shared
CHEMISCH FBRK KRSSLR
Shared indications:
Varicose Veins
SOTRADECOL
SODIUM TETRADECYL SULFATE
1 shared
Viatris
Shared indications:
Varicose Veins
VARITHENA
POLIDOCANOL
1 shared
PROVENSIS
Shared indications:
Varicose Veins
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

SODIUM TETRADECYL SULFATE FDA Label Details

Indications & Usage

SODIUM TETRADECYL SULFATE is indicated for the treatment of Varicose Veins.

Looking for the branded version?

SOTRADECOL

Full clinical data, patents, trials, and competitive landscape for sodium tetradecyl sulfate.

See SOTRADECOL

Data Sources

FDA Approval: ANDA209937 → Label: DailyMed → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.